Healthy plants, but no tomatoes? – GREAT BEND TRIBUNE – Great Bend Tribune

No fruit on your tomato plants is likely due to the weather. Tomatoes thrive in warm, sunny conditions, but temperature extremes can prevent otherwise healthy plants from setting fruit.

When daytime temperatures rise above 90 degrees and night temperatures remain above 70 degrees, blossom drop, and poor fruit development can occur. Combine this with low humidity and the pollen is not viable. In hot and humid conditions, the pollen is too sticky and doesnt move from the male to the female part of the flower. Without pollination the flowers wont be fertilized and fruit will not develop.

Cool weather can also hinder fruiting. Night temperatures below the optimum of 59 to 68 degrees reduce the amount and viability of pollen the plant produces.

The simplest solution is to wait for the temperatures and humidity levels to return to those tomatoes need for pollination and fruit formation to occur. Once this happens, the plants will begin producing fruit.

When hot weather arrives, make sure the plants receive ample moisture. Mulch the soil with shredded leaves, evergreen needles or other organic matter to keep roots cool and moist. Consider providing a bit of cool afternoon shade during hot spells.

Some gardeners enlist the help of blossom set hormone spray when conditions are not favorable for pollination and fruit formation. These hormones wont increase productivity but may help plants set fruit when temperatures are not ideal. These products are most effective when temperatures drop below 60 degrees Fahrenheit. They are less effective at initiating fruit set when temperatures rise over 80 degrees.

Dont let cooler summer temperatures greatly reduce your tomato harvest. Consider pinching off the growing tips of indeterminate tomatoes a month before the first killing frost. This redirects the plants energy into ripening the existing fruit instead of producing more flowers and tomatoes that wont have time to mature.

When frost is in the forecast, harvest green tomatoes to finish ripening indoors. Pick any tomatoes that are starting to show color before the killing frost and finish ripening them indoors. Harvest tomatoes when the blossom end turns a greenish white or starts to color up. Store the tomatoes in a cool 60- to 65-degree location to extend their storage life. And dont let those green tomatoes go to waste. Fry them or use them in salsa and relish. Youll find lots of delicious green tomato recipes online or from friends.

Extend the growing and harvesting season with the help of floating row covers or other season extending strategies. These products protect plants from cold temperatures, allowing you to harvest weeks after the first fall frost.

If poor fruiting is a yearly problem in your garden, look for tomato varieties better suited to your growing conditions. Next season look for recommendations from your local University extension service. They can help you select the best heat or cold tolerant varieties and those that best fit your gardening style and cooking needs.

With the proper selection and care you will enjoy an abundant harvest in spite of less-than-ideal weather conditions.

Melinda Myers is the author of numerous books, including Small Space Gardening. Myers web site is http://www.MelindaMyers.com.

Continued here:

Healthy plants, but no tomatoes? - GREAT BEND TRIBUNE - Great Bend Tribune

Oral Probitoics Market Is expected to Witness Significant Growth between 2020 to 2025| Top Key Players- NatureWise, Now Foods, DS Healthcare, Higher…

Overview Of Oral Probitoics Industry 2020-2025:

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The Oral Probitoics Market analysis summary by Reports Insights is a thorough study of the current trends leading to this vertical trend in various regions. Research summarizes important details related to market share, market size, applications, statistics and sales. In addition, this study emphasizes thorough competition analysis on market prospects, especially growth strategies that market experts claim.

Oral Probitoics Market competition by top manufacturers as follow: NatureWise, Now Foods, DS Healthcare, Higher Nature, NutriPreme, Candidabiotix, Hyperbiotics, Jarrow Formulas, Life Extension, Natren, UltraCruz, Aqua Flora,

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/34513

The global Oral Probitoics market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

The Type Coverage in the Market are: LozengesOther

Market Segment by Applications, covers:Human UseVeterinary

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

Major factors covered in the report:

To get this report at a profitable rate.: https://reportsinsights.com/discount/34513

The analysis objectives of the report are:

Access full Report Description, TOC, Table of Figure, Chart, [emailprotected] https://reportsinsights.com/industry-forecast/Oral-Probitoics-Market-34513

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Read more:

Oral Probitoics Market Is expected to Witness Significant Growth between 2020 to 2025| Top Key Players- NatureWise, Now Foods, DS Healthcare, Higher...

Portland airport hosts first-ever drive-in movie – KTVZ

National & World

Click here for updates on this story

PORTLAND, OR (KPTV) Portland International Airport may be all about planes, but on Friday night, it hosted its first-ever drive-in movie.

The event was put on to celebrate the designers and builders of the newly opened Concourse E extension, which adds six gates to the airport for Southwest Airlines, along with some special features, like a giant art display.

At the drive-in event on Friday, a special video honoring all those who made the project possible was shown right before the feature-length film, Incredibles 2.

The Concourse E extension took two years and more than 2,000 people to bring to life, the airport says. The extension is part of PDXNext, a series of five large construction projects underway at the airport, which will cost in total about $2 billion.

Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.

Read this article:

Portland airport hosts first-ever drive-in movie - KTVZ

The Life and Times of 1990s Superstar Vladimir McCrary – Vogue.com

Where are you from and how did you start modeling?Im from San Antonio, Texas, and I was a professional basketball player. [Ive been playing since I was] five years old. Basketball was always a part of me, and my brothers, my family. For me, a Texas boy growing up in the south, thats what you did, you went outside and played sports. I was on Magic Johnson and Patrick Hewings tour team, we were touring parts of Europe, and I ended up coming to rest in Paris for about a week. Before then I had met a model scout and had taken a few pictures in LA, and didnt think anything more about that. The crazy story is that when I came to Paris, those pictures that I had taken were being used in The Body Shops promotions. The agent that I had met went on ahead and got money behind my back.

I knew nothing about fashion and things of that nature, but I walked around to a few agencies with a completely open mind. [My first stop was] Success; they didnt even look at me. I felt like a fool standing in the corner. Im a very big guy, Im (about) 6 7 and I was about 240 pounds with muscle, so I was not model materialwhatever that was. I didnt know what a model was. Im an artist. For me, a sports person is an artist; what youre able to do on that court or that field, or however you get it done, its art, its creativity, its an extension of yourself.

I [went around] to a few other agencies and ended going into PH1; they didnt really look at me. [But] there was a young girl, 22, it was her first day of work, and she took my pictures back to a guy named Paul Hagnauer, and then she came back and she goes, Hey, come here: Ill work with you. I said, Well, okay, cool. Then she said, Why dont you go over to this casting, its for a big designer.

Who was the casting for?There were maybe like 200 or 300 people there; women, men in makeup. It was hilarious for me to see that; Ive never been in that world, I was always a sportsperson. Then I see that everybody was moving out of the way because somebody was running up the middle of all the models, and this person was Jean Paul Gaultier. He stopped and said to me, Hey, are you the guy with the tattoo on your back? I said, Yeah. He said, Okay, Ill see you upstairs. Eventually I made my way up and approached the table. It was Jean Paul, Tanel, [and a few] other people. So Jean Paul asked me a few questions, and as I got ready to try something on, he said, Oh, by the way, youre in my show.

Follow this link:

The Life and Times of 1990s Superstar Vladimir McCrary - Vogue.com

Oral Probiotics Market Research 2020 by Industry Growth, Business Opportunities, Top Manufacture, Industry Share Report, Size, Regional Analysis and…

Global Oral Probiotics Market Research Report 2020-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.

This is the latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact are covered in the report.

SPECIAL OFFER (Avail a flat 25% discount on this report, please fill the form and mention the code: MIR25 in the comments section)

Click the link to get a free Sample Copy of the Report at:

https://www.marketinsightsreports.com/reports/06242107929/covid-19-outbreak-global-oral-probiotics-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020/inquiry?Mode=24

Key Market Players:

Lallemand, Oragenics, TheraBreath, ProBiora Health, Life Extension, Now Foods, BioGaia, Bluestone Pharma, Bifodan, Hyperbiotics, Jarrow Formulas

Market segment by Type, the product can be split into

Powder

Chewable Tablets

Others

Market segment by Application, split into

Child

Adult

The leading players of the Oral Probiotics industry, their market share, product portfolio, company profiles are covered in this report. The leading market players are analyzed on the basis of production volume, gross margin, market value, and price structure. The competitive market scenario among Oral Probiotics players will help the industry aspirants in planning their strategies. The statistics offered in this report will be a precise and useful guide to shape business growth.

Oral Probiotics Market Report Highlights:

The report provides a detailed analysis of current and future market trends to identify the investment opportunities market forecasts till 2026.

Key Oral Probiotics market trends across the business segments, regions and countries

Key developments and strategies observed in the market

In-depth company profiles of key players and upcoming prominent players

Key market dynamics such as drivers, restraints, opportunities and other trends

Market opportunities and recommendations for new investments

The report has 150 tables and figures browse the report description and TOC:

https://www.marketinsightsreports.com/reports/06242107929/covid-19-outbreak-global-oral-probiotics-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020?Mode=24

TOC Snapshot of Global Oral Probiotics Market

Oral Probiotics Market Product Definition

Worldwide Oral Probiotics Market Manufacturer Share and Market Overview

Manufacturer Oral Probiotics Business Introduction

Oral Probiotics Market Segmentation (Region Level)

World Oral Probiotics Market Segmentation (Product Type Level)

Oral Probiotics Market Segmentation (Industry Level)

Segmentation (Channel Level) of Oral Probiotics Market

Oral Probiotics Market Forecast 2020-2026

Segmentation of Oral Probiotics Industry

Cost of Oral Probiotics Production Analysis

Conclusion

The research includes historic data from 2015 to 2020 and forecasts until 2026 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs

We also offer customization on reports based on specific client requirement:

1- Freecountry-level analysis forany 5 countriesof your choice.

2-FreeCompetitive analysis ofany 5 key market players.

3-Free40 analyst hoursto cover any other data points.

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

[emailprotected] | [emailprotected]

View original post here:

Oral Probiotics Market Research 2020 by Industry Growth, Business Opportunities, Top Manufacture, Industry Share Report, Size, Regional Analysis and...

Australian Vanadium consolidates position with new mining licence to extend flagship project – Proactive Investors Australia

The new mining licence application, complements and extends AVLs position over the deposit at Gabanintha.

() has extended its footprint for the Australian Vanadium Project atGabanintha in WA's Mid-West with a mining licence application covering southern mineral resource fault blocks.

The resource within the lease application area (MLA 51/890) contains inferred resources in fault blocks 60 and 70totalling27.5 million tonnes at 0.76% vanadium pentoxide including 14.8 million tonnes at 0.99% of high-grade (HG) massive magnetite zone.

A 3D Magnetic Inversion model shows that there is anadditional strike of 500 metres with the potential for further high-quality resources pending drilling.

AVL managing director Vincent Algar said: Australian Vanadium has now consolidated its entire strike of mineralisation into mining licence applications, ensuring a strong future for the project.

The mineral resources in MLA 51/890 will not form part of the bankable feasibility study (BFS), but will offer opportunities for optimisation, scaling of production and mine-life extensions in the future.

The proposed process to extract vanadium uses a magnetic separation circuit and AVL has identified that the magnetic susceptibility can be used to target areas that show higher magnetism and less weathering nearer the surface.

A 3D magnetic inversion model was completed using 50-metre aeromagnetic flight lines from a 2006 survey over the entire length of the magnetite with the result aiding targeting for the drilling of fault blocks 50 and 60 completed in December 2019.

The drilling results add flexibility to the mine schedule in the BFS, allowing strongly magnetic material to be processed early in the mine life, increasing vanadium recovery.

Project location and tenure with mining lease application MLA 51/890 southern extension.

The mineral resources defined within the licence area were estimated using results from a series of drilling programs conducted on the deposit in 2008, 2009, 2015 and 2019.

Fault block 70 has an existing inferred mineral resource based on drilling completed during 2008 and 2009, with best results of

The addition of the southern fault blocks to a mining lease application also increases the opportunity for an extension of the mine life at the project.

Mineral resources within AVLs main licence area of 208.4 million tonnes at 0.74% vanadium pentoxide including 87.9 million tonnes at 1.06% of HG zonewill continue to be the primary basis for the BFS.

As well as optimising the mine-life, the new application provides flexibility for future infrastructure works to support two open pits as well as containing waste dumps, topsoil stockpiles, haulage roads and a mining service area.

Original post:

Australian Vanadium consolidates position with new mining licence to extend flagship project - Proactive Investors Australia

Invetx Announces Industry-Leading Antibody Discovery Platform to Develop Portfolio of Novel Therapeutics for Animal Health – Yahoo Finance

Platform Leverages Best-in-Class Technologies from AbCellera, Twist Bioscience and WuXi Biologics

Invetx, a pioneer in protein-based therapeutics for animal health, announced today the launch of its antibody-based platform for the discovery and development of novel medicines for animal health. The proprietary platform combines industry-leading technologies from partners AbCellera, Twist Bioscience and WuXi Biologics to develop fully species-specific, optimized and half-life-extended monoclonal antibodies (mABs) for veterinary use. Invetx has already built a robust pipeline of biotherapeutic programs from its platform and anticipates beginning pilot studies for the first candidates in 2020.

The Invetx platform integrates:

"By integrating these best-in-class technologies in a unique platform tailored to applications in animal health, Invetx is setting a new standard for advanced veterinary protein therapeutics," said Juergen Horn, PhD, chief executive officer, Invetx. "Our vision is to bring next generation veterinary therapeutics to the market that address unmet needs with superior product profiles at affordable prices. Additionally, Invetxs proprietary half-life extension technology will allow for significantly longer dosing intervals, making long-term treatments far more convenient for owners and their pets while helping to improve compliance."

Invetx is developing a portfolio of novel products for chronic and serious conditions in pets with the goal to extend and improve their quality of life. The platform capabilities extend across a wide range of indications and targets, including challenging targets for drug discovery such as G-protein-coupled receptors (GPCRs), which account for a significant number of approved drugs in humans and which are also relevant in veterinary medicine. Invetx is initially focused on diseases in dogs and cats but is planning to apply its platform to indications in other species.

"AbCellera is proud to be a part of Invetxs vision of bringing innovation and state-of-the-art technologies to the animal health market," said Carl Hansen, PhD, chief executive officer of AbCellera. "There is an enormous opportunity to apply the lessons learned and advantages realized in human drug discovery to the benefit of veterinarians and pet owners."

"We are excited to apply our synthetic human antibody engineering and optimization expertise to the field of animal health in collaboration with Invetx," said Emily M. Leproust, PhD, chief executive officer and co-founder of Twist Bioscience. "Like humans, animals also need targeted antibody therapeutics that address serious diseases, but limited access to cutting-edge antibody technologies have hampered development in the animal health field. By applying the same technology we use for human antibody discovery, we are able to engineer and optimize animal therapeutic antibodies."

The global animal health medicines and vaccines market was estimated to be worth $34 billion in 2019. Its forecasted annual growth of more than six percent is driven by increasing pet ownership and spend as well as treatments and vaccines for farm animals. Although biopharmaceuticals dominate human drug development because of their long-lasting effects and ability to precisely address the molecular causes of disease, to date only one monoclonal antibody therapeutic is available for veterinary use in the United States and the European Union.

About Invetx

Invetx is building the worlds premier biotechnology platform for protein-based therapeutics in animal health to transform standards of care in veterinary medicine. In February 2020, the company announced a $15M Series A financing and strategic partnerships with AbCellera, a biotech company specializing in antibody discovery located in Vancouver, BC and WuXi Biologics, a global company with leading biologics technology platforms. Invetx is a private company headquartered in Boston, Massachusetts. For more information, see invetx.com.

About AbCellera Biologics Inc.

AbCellera is a privately held biotech company with a drug discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. AbCelleras technology, which combines high-throughput microfluidics, hyper-scale data science, machine learning, bioinformatics and genomics, identifies new first-in-class drugs and reduces the time it takes to bring treatments to the clinic. AbCellera's partners include leading biotechnology companies, global health organizations and many of the top 10 biopharmaceutical companies. For more information, visit http://www.abcellera.com.

Story continues

About Twist Bioscience

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including diagnostics, therapeutics, industrial chemicals, agriculture and academic research. For more information visit http://www.twistbioscience.com and http://www.twistbiopharma.com.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly one-stop service offering and strong value proposition to our global clients. As of December 31, 2019, there were a total of 250 integrated projects, including 121 projects in pre-clinical development stage, 112 projects in early-phase (phase I and II) clinical development, 16 projects in late-phase (phase III) development and one project in commercial manufacturing. With total estimated capacity for biopharmaceutical production planned in China, Ireland, the U.S., Germany and Singapore exceeding 280,000 liters by 2022, we will provide our biomanufacturing partners with a robust and premier-quality global supply chain network. For more information on WuXi Biologics, please visit http://www.wuxibiologics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200716005250/en/

Contacts

Invetx partners and investors: Juergen Horn, PhDChief Executive Officerjuergen.horn@invetx.com

Invetx media: Susan Kinkeadsusan@kinkeadcomm.com 415-509-3610

AbCellera: Kevin Heyries, PhD, Head of Business Developmentbd@abcellera.com 604-559-9005

Twist Bioscience Investor contact: Argot PartnersMaeve Conneightonmaeve@argotpartners.com 212-600-1902

Media contact: Angela Bittingmedia@twistbioscience.com 925-202-6211

WuXi Biologics media: Kevin Huang, PhDkevin_huang@wuxibiologics.com

Read more from the original source:

Invetx Announces Industry-Leading Antibody Discovery Platform to Develop Portfolio of Novel Therapeutics for Animal Health - Yahoo Finance

The Best Way To Build Wealth In The Long Term – Seeking Alpha

Creating wealth is the main reason why we invest in the stock market. We just want to turn every dollar invested today into a large sum in the future, always keeping risk under consideration in the process.

I am not going to say that creating wealth is easy to do by any means, because it is not. However, creating life-changing wealth is far from impossible when investing in high-quality growth stocks over long periods of time.

The table below shows the future value of $100.000 invested at different rates of return over different periods of time. We go from 5 years to 50 years and from 10% annual returns to 20% annual returns.

When you remain invested over 15 or 20 years, the chances of transforming $100,000 into $1 million are pretty reasonable, and you don't even need extraordinary returns to achieve this target. Even better, once you go beyond 25 years, the effects of compounding are downright astonishing.

Even 10% annual returns can turn $100,000 into $1.08 million in 25 years, and the future value grows to $3.3 million and to $9.5 million if the return increases to 15% and 20% respectively.

Over longer periods of time, the impact of compounding can be mind-blowing for investors who are not familiarized with these numbers.

Source: Author's calculations

Maybe you are thinking that you don't have enough time to achieve this kind of performance, but it is important to keep in mind that medical advancements are offering enormous possibilities for life extension in the years ahead. Besides, when you start thinking about creating wealth for your children or grandchildren, the time horizon of your investment increases exponentially.

I am not going to get a Nobel Prize in economics for saying that generating strong rates of return over long periods of time can create enormous amounts of wealth. However, the point is that most investors tend to lose sight of the big picture when focusing too much on the short-term.

We know that we want to achieve high rates of return over long periods of time; this is beyond discussion. The big question then is how do we do that.

There are all kinds of possibilities, and different strategies are better suited for different kinds of people. In my opinion, investing in top-quality growth stocks for the long term is one of the best ways to maximize your chances of success in this fascinating endeavor of wealth creation.

This is not an easy path because it requires a long-term view, a strategic mindset, and conviction. However, long-term growth investing does not require you to be an expert in forensic accounting or to be watching stock prices every second of the day. It is a viable strategy for high-conviction investors who are not investment professionals or even full-time investors.

Stock prices are very volatile in the short term, but over the long term, prices go in the same direction as revenue and profits. In essence, a stock is a share in the ownership of a business, so shares in businesses that deliver superior growth over long periods of time tend to deliver superior returns too.

Many investors tend to worry about the fact that high-quality growth stocks generally trade at above-average valuation levels. This is a valid reason for concern, and we need to always consider valuation in the decision-making process, especially in the current market environment.

However, it is unreasonable to expect the best businesses in the world to trade at discounted valuations. If you focus solely on the price tag and you don't pay enough attention to quality, you may end up missing many of the most promising opportunities for wealth creation in the stock market.

More importantly, if you find the right companies and hold them for the long term, then the quality of the business is much more important than your entry price.

We could say that the price return depends on two main variables, the change in fundamentals and the change in valuation levels. Let's focus on the price to sales ratio since sales are generally a cleaner metric than earnings. The price of the stock will depend on how the sales of the company evolve and how the price to sales ratio evolves.

Price = Sales x Price/Sales

Then

Change in Price = Change in Sales x Change in Price to sales

It is very difficult to know how the price to sales ratio will move because this depends on general market conditions and the opinion of other investors to a good degree. However, if the company's sales increase exponentially over the years, there is a good chance that the investor will be rewarded with attractive returns, even if the price to sales ratio declines.

The chart below shows revenue per share and the price to sales ratio for Square (NYSE:SQ) over the past several years. Revenue growth has been very strong, but the price-to-sales ratio is currently below the highs from 2018.

Data by YCharts

The point is that the stock has still produced massive gains for investors over the years. There has been a lot of volatility along the way, but growing sales and earnings generally produce price gains over the long haul, even if valuation levels can fluctuate in either direction.

Data by YCharts

It is very important to understand that current valuation ratios reflect market expectations about the future of a business. If the company can outperform those expectations and build new growth engines over time, valuation ratios will tend to increase. In these cases, investors win both ways: revenue increases and the price-to-sales ratio raises, too.

Sea Limited (NYSE:SE) has long been a leading online games platform in South East Asia, and the company is now successfully expanding into online commerce and fintech. These new markets are opening many exciting doors for Sea Limited, so revenues are growing strongly and the price-to-sales ratio has more than doubled in the past year due to increased expectations for further growth.

Data by YCharts

Because of these factors, the stock has delivered explosive returns for shareholders, and it still has plenty of room for gains if management plays its cards well and continues executing in the years ahead.

Data by YCharts

In simple terms, you want to buy companies with strong competitive advantages, visionary management teams, and operating in industries with plenty of potential for sustained growth and innovation.

Valuation should not be disregarded, but when you hold positions over several years and the company can exceed market expectations while building new growth engines over time, valuation is generally not as important as picking the right business.

If you are right about what to buy, and you hold it for the long term, then when to buy it is generally less important than you think. Unless the stock price is egregiously overvalued, the sooner you can start buying a high-quality business, the better.

Many investors consider growth stocks too risky and volatile. In this regard, it is important to understand that risk can always be managed with position size. Buying the right growth stocks and holding on to them over the long term can produce huge returns with a relatively small amount of capital.

You can keep a large share of your savings in low-volatility investments and aim for superior returns with long-term positions in high-octane stocks. Risk is not only what you buy, but, more importantly, also how much you buy.

Also, investing for the long term does not mean "buy and forget". If the fundamental thesis is broken or valuation does not provide any room for upside, then the smart thing to do is selling the position. Risk and return should be assessed with a long-term mindset, but it is still important to actively follow the company and adjust your investment thesis accordingly.

Building large amounts of wealth is not easy, and trying to do it quickly can do more harm than good. However, for investors with patience and a long-term horizon, investing in high-quality growth stocks can be a powerful strategy for wealth creation.

A subscription to The Data Driven Investor provides you with solid strategies to analyze the market environment, control portfolio risk, and select the best stocks and ETFs based on hard data. Our portfolios have outperformed the market by a considerable margin over time, and The Data Driven Investor has an average rating of 4.9 stars out of 5. Click here to get your free trial now, you have nothing to lose and a lot to win!

Performance as of July 14, 2020

Disclosure: I am/we are long SQ, SE. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: I replicate the Data Driven Portfolio with my personal money.

Link:

The Best Way To Build Wealth In The Long Term - Seeking Alpha

GlobalData : British Airways decision to retire 747 fleet is expected with increased efficiencies of more modern platforms – Marketscreener.com

17 Jul 2020British Airways decision to retire 747 fleet is expected with increased efficiencies of more modern platforms Posted in Aerospace, Defense & Security

Following the news that British Airways is retiring its entire 747 fleet, Anthony Endresen, Aerospace and Defense Analyst at GlobalData, a leading data and analytics company, offers his view:

'British Airways decision to retire its 747 fleet earlier than expected is not that surprising given the significantly reduced passenger market landscape and the increased efficiencies of operating fleets of more modern platforms such as the Airbus A350. This decision is simply a case of bringing forward what was always a pending retirement, rather than the collapsed passenger market being the cause of the move.

'Most cancellations, deferrals and retirements will currently be ascribed to COVID-19, whereas in this instance, it is mostly a case of the timeline being changed. The aspect that is in fact COVID-19 driven is the question of platform and service types that will replace the 747, as the market has not just contracted, but has in fact changed. The outlook for the commercial aviation market recovery means increased efficiencies will be sought, with fuller flights and potentially leaner services. These characteristics, and the historical pattern of single aisle platform market segments returning faster after crises, point to the timely introduction of alternative aircraft and aircraft types. 'GlobalData's recent poll points to this being part of a complex pattern with segment nuances, with 41% of respondents anticipating the leaner market in fact seeing older models' service lives being extended. This poll did not differentiate specific aircraft models, with life extension being more likely in single aisle types.'

Disclaimer

GlobalData plc published this content on 17 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 July 2020 21:40:05 UTC

Read the rest here:

GlobalData : British Airways decision to retire 747 fleet is expected with increased efficiencies of more modern platforms - Marketscreener.com

MyndTec and University Health Network Extend Partnership focusing on advances in technology to improve lives of people living with the effects of…

MISSISSAUGA, ON, July 14, 2020 /PRNewswire/ - MyndTec Inc., an award-winning Canadian medical technology company, and University Health Network (UHN), Canada's largest medical research hospital,have announced the extension of an exclusive license agreement. The partnership positions MyndTec at the forefront of new technology in the neuromodulation and neurorehabilitation field.

The partnership, established in 2012, has culminated in the development and commercialization of MyndMove Therapy in the U.S. and Canada. MyndMove is a non-invasive functional electrical stimulation technology that assists those living with paralysis following stroke or spinal cord injury by helping restore arm and hand function. The collaboration reflects the company's commitment to addressing an important need in neurorehabilitation.

"This partnership allows our research teams to rapidly develop and commercialize new products designed to restore function for people living with disabilities," said Steven Plymale, CEO of MyndTec. The research and development of MyndMovewas pioneered by Dr. Milos R. Popovic and the research team at KITE, the research arm of the Toronto Rehabilitation Institute and one of UHN's principle research enterprises. "We are thrilled to extend the agreement and look forward to working with MyndTec to bring to market high-tech innovations developed in our labs," said Dr. Popovic, KITE Institute Director.

About MyndTec

MyndTec Inc. is a privately held medical technology company located inMississauga, Ontario, that commercializes innovative therapeutic medical devices designed to improve function, maximize independence, and enhance quality of life. MyndTec's product MyndMove is a non-invasive functional electrical stimulation-based intervention. MyndMove uses the phenomenon of neuroplasticity to stimulate development of new neural pathways to assist those with paralysis following a stroke or spinal cord injury to regain control of their arms and hands.

For more information on MyndMove and authorized indicationsvisithttp://www.myndtec.com.

The Kite Research Institute

KITE is the research arm of the Toronto Rehabilitation Institute and one of the principle research enterprises at the University Health Network, Canada's largest medical research hospital. KITE is a world leader in the field of the complex rehabilitation research, with scientists and staff dedicated to improving the lives of people living with the effects of disability, illness and aging.

SOURCE MyndTec Inc.

Home

Go here to see the original:

MyndTec and University Health Network Extend Partnership focusing on advances in technology to improve lives of people living with the effects of...

China to Sanction Lockheed Martin Over Arms Sales to Taiwan – CapitalWatch

author: Belinda Zhou

Beijing announced on Tuesday it would place sanctions on American arms giant Lockheed Martin Corporation for its role in the $620 million U.S. sales of Patriot missile deal with Taiwan.

"In order to safeguard national interests, China decided to take necessary measures to impose sanctions on Lockheed Martin, the chief contractor in this arms sales case," Lijian Zhao, a foreign ministry spokesperson said at a press conference.

Details of the ensuing penalty have yet to be disclosed.

The United States has approved an upgrade package with an estimated cost of $620 million for Patriot surface-to-air missiles to Taiwan,according tothe State Departmenton July 9. Taiwanhas requested to buy components to upgrade its Patriot missiles "in order to support an operational life of 30 years," as Reuters reported.

"This proposed sale serves U.S. national, economic, and security interests by supporting the recipient's continuing efforts to modernize its armed forces and to maintain a credible defensive capability," the state department said.

This arms sale is the second approved by the Trump administration to Taiwan this year and the seventh since Trump's presidency.

The American-made Patriot Advanced Capability-3 missiles are deployed around major cities and important military facilities in Taiwan.

Taiwan's Defense Ministry confirmed on Friday that the arms will be used for training purposes and the training goal is intercepting missiles from mainland China. The ministry also said it expected the deal to take effect within the next month.

Since 2007, the United States has announced the sale of Patriot Advanced Capability-3 to Taiwan in three batches; these missiles were delivered to Taiwan from around 2011.

"The oldest system and missiles have been in service for nearly 10 years and it's time to update it," Fuxing Mei, the director of the Taiwan Strait Security Research Center, said.

"It is estimated that the life-extension case will not be completed until at least 2022," Mei added.

Zhao urged the U.S. government to effectively abide by the One-China principle and stop selling arms to Taiwan to avoid deepening the chasm that exists between the two nations already.

China's "One China principle" asserts that there is only one sovereign state under the name China. In the 1992 Consensus, thePeople's Republic of Chinaand theRepublic of China of Taiwan both accepted this principle, but interpret it differently. Both Taiwan and the PRC agree there is only "One China" but both governments disagree as to which is the legitimate government representing this "One China."

A violent border conflict between India and China has also raisedthe demand defense systems in Beijing, sending Chinese defense-related stocks to rise.

"Looking forward to the whole year, with the overtime work after the resumption of work, most of the military industry's revenue and performance will resume growth since the second quarter," Kang Shi, an analyst from China Industrial Securities Co Ltd., wrote in his analysis, giving a 15% growth rate prediction for 2020.

Shares in Lockheed Martin closed at $355.59 per share on Tuesday, up 1%.

Excerpt from:

China to Sanction Lockheed Martin Over Arms Sales to Taiwan - CapitalWatch

Minerao Vale Verde and Appian Announce First Blast and Implementation Update at Serrote – PRNewswire

LONDON, July 14, 2020 /PRNewswire/ --

Highlights

Minerao Vale Verde Ltda. ("MVV" or the "Company") and Appian Capital Advisory LLP ("Appian") are pleased to announce first blast and an implementation update for the Serrote copper-gold project ("Serrote") located in Alagoas, Brazil. Appian also announces support to combat the COVID-19 pandemic in the country.

First blast and implementation update

On 20 June 2020 MVV achieved first blast at Serrote, marking a major milestone of the open-pit development with the pre-stripping program having now handled over one million tonnes of material. The Company continues to de-risk and progress Serrote to schedule and under budget, with overall project execution tracking at ~60% complete. Procurement is approaching the final stages with 96% of key packages by value awarded and start-up expected during H2 2021.

First blast marks yet another significant development milestone following completion of Serrote's previously announced definitive feasibility study ("DFS"), which outlined a conventional, low strip open pit operation producing 20ktpa of copper equivalent at second quartile costs over an estimated initial mine life of approximately 14 years. The robust project economics outlined in the DFS led to a positive construction decision with Appian funding all of the equity required to bring the asset into production.

MVV is taking necessary precautions to ensure the health and safety of employees and local communities and continuity of project implementation in the wake of the COVID-19 pandemic. Other recent development highlights include:

MVV is in advanced discussions on the previously announced US$160 million senior bank project financing facility as well as other non-dilutive funding options and expects to reach financial close during the second half of this year.

Upcoming milestones

As Serrote continues to progress in line with the construction plan, MVV is targeting the following milestones by the end of 2020:

Initial mine life extension opportunities

MVV is pursuing several expansion opportunities beyond the initial 14-year mine life, with significant defined mineralization outside of the current mine plan as well as numerous satellite resources and targets within trucking distance of the planned plant infrastructure. Less than 50% of the 112Mt global resource is currently contained within the mine plan, with active exploration and growth plans underway to increase mineable inventory.

In addition, MVV is stockpiling Serrote's oxide resource for future processing as part of the pre-stripping activities. With 19Mt of oxide resource at Serrote grading 0.5% copper and additional near-surface oxide material present at satellite deposits, MVV is evaluating the processing of oxides via SX-EW on-site to produce copper cathodes.

COVID-19 support for local communities

Brazil is one of the countries that has been worst affected by COVID-19 globally. Appian has announced a US$600,000 support package to help combat the pandemic in the regions in which its portfolio companies operate, through its philanthropic vehicle, the Appian Way Charitable Foundation ("AWCF"). To date, AWCF's support includes procuring 6,000 Covid-19 Rapid Test Kits, 12,000 N95 masks, 25,000 white surgical masks and 70 non-contact digital infrared forehead thermometers for use in Alagoas where Serrote is situated, and Bahia, the location of Appian's Santa Rita nickel sulphide project.

AWCF has also distributed more than 40 tons of materials packed into hygiene kits to community members, with all materials carefully sourced to support local businesses. In Bahia, AWCF also contributed to fund a health unit dedicated to treat COVID-19 patients. On the food security front, AWCF has distributed more than 8 tons of food supplies for at-risk families.

This supplements Appian's work with both MVV and Atlantic Nickel to improve the quality of life for underprivileged children and women within the communities around the operations.

Paulo Castellari, CEO MVV & Appian Brazil commented:

"I am pleased with the continued progress at Serrote, and first blast marks another major milestone on the road to production, which remains on track for the second half of 2021. Construction works are progressing as planned, as we build on the project's strong fundamentals to develop the asset on schedule and under budget.

"Serrote continues to demonstrate robust economics with potential upside, and we are seeing strong interest from offtake and financing partners, which underlines the progress that MVV and Appian have made in developing and derisking the project, along with the attractiveness of Serrote's high-grade copper-gold concentrate.

"Environmental, Social, and Governance efforts continue to be fundamental to our business, and I am proud of our actions to help combat the COVID-19 pandemic in Brazil, to support and partner with the communities in which we operate."

About Minerao Vale Verde Ltda.

MVV is developing Serrote, an advanced stage, de-risked greenfield open-pit copper-gold development asset currently under construction and with all major permits in place, located in Alagoas, Brazil. The Company is headquartered in Belo Horizonte, with a high-quality management team with extensive local and international experience operating at site.

Following Appian's acquisition of the asset in mid-2018, an updated DFS was completed outlining a 14-year initial mine life with production of approximately 20 thousand tonnes of copper equivalent per annum in a premium, high grade concentrate. Serrote is expected to be well positioned in the second quartile of the copper cost curve on a total cash cost basis.

MVV is pursuing several expansion opportunities beyond the initial mine life, with significant defined mineralization outside of the current mine plan as well as numerous satellite resources and targets within trucking distance of the planned plant infrastructure. Less than 50% of the 112Mt global resource is currently contained within the mine plan, with active drilling and growth plans underway to increase mineable inventory.

About Appian Capital Advisory LLP

Appian Capital Advisory LLP is the investment advisor to long-term value focused private equity funds that invest solely in mining and mining related companies.

Appian is a leading investment advisor in the metals and mining industry, with global experience across South America, North America, Australia and Africa and a successful track record of supporting companies to achieve their development targets, with a global operating portfolio overseeing around 3,000 personnel.

About the Appian Way Charitable Foundation

AWCF is Appian's philanthropic vehicle. Appian regards social, environmental and governance standards as crucial elements within all investment opportunities and portfolio companies.

The main focus area for AWCF is children, women and the disenfranchised, and it seeks to contribute to the health and equal education of children in the communities and principal regions into which Appian invests with the aim of contributing to lifting people out of poverty, improving long-term environmental stability and health and empowering women and girls.

For further information:

Finsbury:+44-(0)20-7251-3801,[emailprotected]Charles O'Brien, Ruban Yogarajah, Richard Crowley

Appian Capital Advisory: +44-(0)20-7004-0951,[emailprotected]Michael W. Scherb, Guy de Freitas

SOURCE Appian Capital Advisory LLP; Minerao Vale Verde Ltda

Private Equity For the Mining Industry

Read this article:

Minerao Vale Verde and Appian Announce First Blast and Implementation Update at Serrote - PRNewswire

The NHLPA’s Don Fehr on the Olympics, bubble life, coronavirus testing and more – ESPN

Jul 14, 2020

Emily Kaplan

Greg Wyshynski

Last Friday, the NHL's owners and the players approved a new collective bargaining agreement as well as the league's return-to-play plan to finish out the 2019-20 season in two bubbles this summer. It's six seasons of labor peace for a sport that hasn't seen much of it over the last 30 years.

The bubbles exist for the same reason this CBA was ratified: The coronavirus and its economic impacts changed the math and shifted the timeline in these talks.

"We viewed the task as trying to identify the difficulties caused by the pandemic, certainly the immediate ones, but looking to the future, to figure out a way to address those issues. We had to do that in a way everybody could agree with -- in negotiations, great ideas aren't worth very much if the other side doesn't go along with it -- and then to set the stage for the recovery when things begin to return to normal," said Don Fehr, executive director of the National Hockey League Players Association.

"This is probably not something that a lot of people are going to call a perfect agreement. A lot of people are going to find faults with one thing or another. That's always the case. And I'm pretty sure there's going to be unanticipated events and perhaps even unintended consequences. But I do think this agreement meets the challenge, and the next challenge is going to be to implement it both in the short-term and in the long-term, and there's a lot in this agreement, I think, players can be proud of."

We spoke with Fehr on Sunday about the CBA, a return to the Olympics in 2022 and 2026 (pending an IOC deal with the NHL), player medical privacy concerns with COVID-19 testing, what next season will look like and whether this, in fact, is his last negotiation as NHLPA chief.

ESPN: The Olympics agreement seems like a huge victory for the players because this is something they were really passionate about. Can you take us through how it came to be -- how much of a priority was it, or a sticking point was it for the players to get something in writing?

Fehr: We had ongoing discussions with the NHL about the importance of the Olympics, both in terms of the players' desire to play, what it means to them to be able to play for their country, and in our view what the marketing advantages could be. We had some ongoing discussions with IIHF and the IOC about that. We thought they'd been progressing well. The NHL wasn't as satisfied. But as we got into this process after having missed Korea, it was basically this has to be in an agreement. And at some point, the NHL, I don't remember exactly when, understood that that was the case.

As a matter of fact, one of the reasons the extension is four years is that it sweeps in the 2026 Olympic Games. Our initial proposal was that it only be a three-year extension. And after that point, which was some months ago, there wasn't a lot of discussion about it. It was just sort of assumed. Bear in mind, though, that we still do have to reach agreement with the IOC and the IIHF, although in my own view, that will take some work but we should be able to get it done without major difficulty.

2 Related

ESPN: The NHL had talked about the Olympics being tied to a larger international calendar of events, like the World Cup of Hockey, but there was nothing in the CBA about that. Were you surprised the Olympics got done without needing that?

Fehr: I think the answer to that is no. I was not surprised because trying to focus on the longer international calendar in the midst of COVID-19 was not a front-burner item for us, for obvious reasons. That being said, I do expect we're going to end up with a longer international calendar. I do expect we're going to end up with World Cups on a regular basis, and all the rest of that. It's just not contained in writing in this agreement.

ESPN: Other pro sports leagues have talked about salary adjustments as a reaction to COVID-19 revenue losses, and NHL owners have used salary rollbacks and compliance buyouts in the past to deal with large contracts. How did you avoid a salary rollback or buyouts in this deal?

Fehr: Once it became clear that what we were looking at was not reducing the cap, it was not something that was necessary. It never came up. If somehow we had been looking at reducing the cap to $65 million, which is roughly what it would have been if we didn't have this agreement and we were going just based on revenues, then it would have arisen. If you think about it from the owners' standpoint, it's [about] the total dollar cost that's involved, which is more important than the individual player costs. And the cap goes up and down, in theory.

ESPN: What did you tell pending free agents about the flat cap next season, and maybe the following season?

Fehr: That it's going to be tough, but if the cap had crashed to the mid-60s, it would have been a lot worse.

ESPN: Escrow is always an issue for players. You made some improvements to escrow in this agreement, including capping it, but is there a chance in the future that there could ever be a total financial restructuring? Or can players always expect to have an escrow system?

Fehr: Well, I've got several answers. The first one is that my brain hasn't gone into future gear yet.

But I guess I would explain it this way. I'm going to explain it in a very neutral, sort of academic way. If management wants to negotiate with the union wages, but not individual wages -- either because they don't think it's a good idea or they don't think the union are going to agree to it -- because normally, in a union-management contract, you have wages covered. You're Joe Jones and you slot in this particular place, and that's that. If they're going to negotiate an overall wage bill -- whether it's a hard dollar amount, whether it's a percentage of revenues, whether it's any other number -- and then you're going to have a system which allows variance on the individual teams for their portion of that bill can be higher or lower by some degree or all the rest of it, you have to have a mechanism to balance the books, otherwise it doesn't work.

So now let me fast forward to your question: Would you see it ever changing? I've been doing this, you know, forever, basically since Moses walked the Earth. I was present during the initial baseball free agency stuff. I was the lawyer in Kansas City who shepherded the free-agency cases through the courts. There weren't any free markets in baseball back then, it was a completely closed market. It wasn't a cap, they just had the old fashioned reserve system. And that changed. And there had been periodic fights in baseball about that, and there are rumors there's going to be another one coming up in the next negotiation [in MLB] in a year and a half. Every league and every negotiation is different based on the time, the circumstances, the dynamic in and all the rest. So, I don't ever say "never" about anything. I think it's possible. Is it likely? I think that'll depend on what the economics are and the mood of the players.

Let me throw one other thing at you; this is important, too. And that is the single biggest determinant of the player salaries is not the system. It's not whether you have a salary cap at 50 percent [of hockey-related revenue] or you don't. It's what the revenue number is. That's significantly more important than the percentage.

With the NHL on pause since March 12, the league and players' association have come up with a return-to-play format featuring 24 teams.

Details on the return-to-play plan Latest updates from around the NHL

ESPN: What was the players' ultimate input on return-to-play protocols? In particular, on the selection of Toronto and Edmonton as the hub cities? Was it one-sided? Collaborative?

Fehr: It was collaborative. [Pauses] I hate that word, because it doesn't capture the process very well. There was a professional working relationship that included players and club officials. It included highly respected physicians on both sides. It included ongoing discussions with local health authorities. The reason you wait to make decisions is partially because the speed of events was so fast that it was hard to be confident about the choices you make in March for what you were going to do in the middle of July or August. It wasn't easy.

Was there any hostility? I guess the best I can tell you is that the choices weren't easy and when to make them wasn't easy, but there wasn't any discord in the process of doing it. We just talked it through. This is where we go to. There wasn't much disagreement about it.

ESPN: How will the beginning of next season be determined? Will the NHLPA have to agree upon it, and negotiate health and safety protocols?

Fehr: First, we know we're going to start late. The odds on that are overwhelming. We still think we can get a full season in if we do some manipulations with what the schedule would otherwise be without going too far ahead of that. And that's certainly the goal.

Secondly, the precise dating on it and the rest of it is yet to be determined. Third, there will very likely have to be health and safety protocols put in place because we hope we are going to be back to playing out of the home arenas. So the answer to that, yes. Those have yet to be negotiated. I am assuming that that's going to be easier to do than it was the first time, because we now have prototypes in place.

ESPN: What would you say to those who think positive tests for players should be disclosed like any other injury or illness? Or that since these names might come out anyway, that not releasing them puts teammates or teams in a bad spot?

Fehr: Essentially in this country, what we believe in is that certain medical things are private unless somebody chooses to make them public. That's difficult to maintain in an industry like ours, but you do the best you can across the board. Somebody saying they have the right to know ... legally, they probably don't.

For example, in your job, suppose we're back in the old-fashioned newspaper days. You're at the city desk with 77 other people in the room with typewriters, and you had to leave and do something for a while. People didn't have a right to anything except that you were gone. They probably know you were gone for a medical reason, but whether it was cancer or a drug rehab or someone in your family was sick, it was none of their business unless you told them. Now, if you had a communicable disease, they would have contact traced everyone you were in contact with.

ESPN: With due respect, no one is betting on my performance at the typewriter. There will be wagering on NHL playoff games, which is something the league has encouraged. There's a perception that a concussion or a knee injury is one thing, but a disease where the rest of the team can be infected is on a different level.

Fehr: We'll have to face that when we come to it. But if the people who are betting on games think the information is insufficient to make a bet, they shouldn't bet.

Emily Kaplan and Greg Wyshynski take you around the NHL with the latest news, big questions and special guests every episode. Listen here

ESPN: How confident are you that players are going to be satisfied with the experience in the bubble, and we're not going to see reports of less-than-promised conditions regarding food or accommodation that we've seen with some other leagues?

Fehr: Well, I think the fact that the NBA photos came out will help prevent that. The proof will be in the pudding when we get there. But I'm reasonably satisfied we'll be able to do that. We've been talking from the beginning about creating bubble atmospheres and bringing in what somebody -- maybe Steve Mayer at the NHL -- called pop-up restaurants from people that really know what they're doing.

I'm not terribly concerned about that. In these circumstances, you do the best you can. But I'm certainly hopeful that that will not be an issue. If it is an issue, you'll hear about it more than once.

ESPN: We asked Gary Bettman this on Saturday, so we'll ask you: Is there a threshold of positive tests in return to play that you think would necessitate a reconsideration of it?

Fehr: Yes, when my doctors tell me that it's something that we have to think about, and that something has happened that they think is severe enough that it raises that issue. That's how we're going to handle it. Look, neither Gary nor I have the kind of medical or public health training that's necessary to make those kinds of judgements. We have to rely on the experts to tell us what to do. The NHL has its own doctors. We have Dr. John Rizos [NHLPA medical consultant], who's been with us for years. We have Dr. Isaac Bogoch, an infectious disease specialist at Toronto General Hospital, who's about as good as they come. We're going to rely on them to tell us what to do.

ESPN: Finally, we now have labor peace for the next six seasons. Was this your last rodeo? Or do you think you'll be at the negotiating table again for the next CBA?

Fehr: Do they have a fountain of youth drug yet? [Laughs] The answer is I don't know. I'll be 72 on July 18. As we go through this, I'm going to have to figure out what makes sense. I expect to be around for a while.

See the rest here:

The NHLPA's Don Fehr on the Olympics, bubble life, coronavirus testing and more - ESPN

Bilberry Extract Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2017 2025 – Jewish Life News

A new intelligence report Bilberry Extract Market has been recently added to Adroit Market Research collection of top-line market research reports. Global Bilberry Extract Market report is a meticulous all-inclusive analysis of the market that offers access to direct first-hand insights on the growth trail of market in near term and long term. On the basis of factual information sourced from authentic industry experts and extensive primary industry research, the report offers insights on the historic growth pattern of Bilberry Extract Market and current market scenario. It then provides short- and long-term market growth projections.

Projections are purely based on the detailed analysis of key market dynamics that are expected to influence Bilberry Extract Market performance and their intensity of impacting market growth over the course of assessment period.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/17752

In addition to evaluation of dynamics, the report provides in-depth examination of key industry trends that are expected to act more prominently in global Bilberry Extract Market. The study also offers valued information about the existing and upcoming growth opportunities in Bilberry Extract Market that the key players and new market entrants can capitalize on.

Competitive companies and manufacturers in global market

Key Players

Some of the prominent manufacturers of Bilberry Extract are Now foods, Natrol, Source Naturals, Inc.,

Bio Botanica, Inc., Life Extension, Athelas Nutraceuticals, Natures way, Swanson and other regional players.

The report covers exhaustive analysis on:

Regional analysis forBilberry Extract Market includes:

Report Highlights:

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/17752

Opportunity assessment offered in this Bilberry Extract Market report is important in terms of understanding the lucrative areas of investment, which prove to be the actionable insights for leading market players, suppliers, distributors, and other stakeholders in Bilberry Extract Market.

In-depth global Bilberry Extract Market taxonomy presented in this report provides detailed insights about each of the market segments and their sub-segments, which are categorized based on t par various parameters. An exhaustive regional analysis of global Bilberry Extract Market breaks down global market landscape into key geographies.

Regional outlook and country-wise analysis of Bilberry Extract Market allows for the evaluation of multi-faceted performance of market in all the key economies. This information intends to offer a broader scope of report to readers and identify the most relevant profitable areas in global market place.

Key Regions and Countries Covered in Global Bilberry Extract Market Report-

Taxonomy and geographical analysis of the global Bilberry Extract Market enables readers to spot profits in existing opportunities and capture upcoming growth opportunities even before they approach the market place. The analysis offered in report is purely intended to unroll the economic, social, regulatory and political scenarios of the market specific to each region and country, which could help potential market entrants in Bilberry Extract Market landscape to understand the nitty-gritty of target market areas and devise their strategies accordingly.

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/17752

Bilberry Extract Market Table of Contents

Read more from the original source:

Bilberry Extract Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2017 2025 - Jewish Life News

‘Best job I could have ever asked for’: Manitowoc County ag agent retires after 33 years – Wisconsin State Farmer

Scott Gunderson(Photo: Sevie Kenyon/UW-Madison CALS)

Scott Gunderson knew he wouldn't be a farmer at an early age.

He grew up in a family of five brothers on a small dairy farm of 10 cows. He had a passion for animals from the beginning, but one of his older brothers ended up taking over the farm before he could.

But his love for farms, dairy farming in particular, still kept him on the path to pursue a career in agriculture.He went to the University of Wisconsin-River Falls and got a degree in agriculture education, then went on to Colorado State University for his Master's in animal science.

What he didn't expect, he says, was that he would become Manitowoc County's Extension ag agent, specializing in dairy, for the next 33years after he graduated with his second degree.

"I was 25 when I started this job," he said. "I really didn't know what the future held. ...I think it's the best job I could have ever asked for."

Since then, Gunderson has become one of the most well-known ag educators in the state. He co-founded the Farm Wisconsin Discovery Center in 2018. He served as vice-chair of the Extension Department of Agriculture and Life Sciencefor nearly a decade. He was a mentor to new agents and educators across the state for 25 years.

Most of all, he helped hundreds of farms to streamline their dairy management, helping them run the best farm they could. Gunderson said one of the best parts of the job was sitting at a kitchen table on a farm, just getting to connect with people and help them improve both their business and their lives.

"I love to see people improve themselves," he said. "That doesn't mean, if you're a farmer, that you have to go from 100 cows to 1,000 cows. Absolutely not. I've always thought getting better before bigger is the key."

UW-Extension Agent Scott Gunderson of Manitowoc County checks out one of the interactive displays at the Farm Wisconsin Discovery Center.(Photo: Colleen Kottke/Wisconsin State Farmer)

Gunderson wasn't just borna good teacher - he said he also learned from the best. One of his most memorable mentors who helped him early in his career was James Crowley, a Ph.D. candidate at UW-Madison. Crowley's extensive experience in dairy nutrition, which Gunderson said was a very small field during the 1980s, helped him develop his own passion for specializing in dairy management.

Gunderson especially became interested in learning more about dairy herd improvementtesting. He helped work on a software called Badger Balance, which served as a virtual dietitian for cows by measuring butter fat and protein levels in milk samples and recommending diet plans based on the data.

"It all depends upon what the farm's needs are," he said. "You can see, over time, what the development is ... leading that successful transition from mom and dad to the next generation."

Carl Duley, Buffalo County's own extension agent, was the one to refer Gunderson to the job all those years ago. Gunderson was studying for his bachelor's degree in ag education at UW-River Falls when Duley was going for his Master's in the same field. Since then, they've been friends and colleagues.

Duley has served as the Buffalo County agent for 35 years and has joined Gunderson in ag education efforts from time to time. While the two have worked on opposite sides of the state for decades, Duley said Gunderson has always been his go-to person to call about anything dairy.

"He's always willing to help," Duley said. "Scott always had a good attitude. I think in today's world in agriculture, especially in the last ten years or so, it's been kind of hard to stay positive. But Scott always was."

Duley added that Gunderson is a good mentor to others, driven by his love for Wisconsin agriculture.

"He was able to keep his ideas, his teachings (and)his techniques fresh. I don't think he ever really got stale at his job," Duley said. "The State of Wisconsin is going to miss him."

Traveling and volunteering are on Gunderson's retirement to-do list. While traveling is made difficult right now due to the pandemic, he said he plans on getting more involved with volunteer work at the Wisconsin Farm Discovery Center. He's also considering volunteer consultation for some farms, but noted that those plans aren't set in stone.

He also wants to spend time in the great outdoors. One of Gunderson's favorite places to go fishing, hunting and logging is the Chippewa Falls area, he said. His father was a logger, cutting pulp for paper mills and stripping the bark off poplar trees,sohe said logging is "in his blood."

"I'm not going to retire to immediately go back to work, I'm going to check things out for now and see how I like it," he said. "We do have some plans though."

Scott Gunderson, center in yellow, at a Dairy After Hours event held at Meadow Brook Dairy Farms in Manitowoc in 2005.(Photo: Scott Gunderson)

Due to a hiring freeze in the UW system because of the coronavirus, Gunderson is unsure when his replacement will be hired. He said thinking about the future of his position is troubling because of budget cuts in the university system the administration is considering combining the Manitowoc County extension system with neighboring counties, he said, which may reducethe ability of the office to respond to local farmers with questions and concerns.

He said it's important to keep the Manitowoc County ag agent position dairy-specific, because Manitowoc County is always in the top five counties in milk production for Wisconsin and top 25 in the nation. He also said centralizing the office will make it harder to be involved in local committees, advisory boards and event planning. Gunderson served on

Regardless of the office politics, Gunderson said he's kept the same framed quote hanging in his office for the past 20 years: "Choose a job you love, and you will never have to work a day in your life."

"I live by it ... andI truly believe that."

Read or Share this story: https://www.wisfarmer.com/story/news/2020/07/13/scott-gunderson-retires-uw-extension-system-after-33-years/5391654002/

More here:

'Best job I could have ever asked for': Manitowoc County ag agent retires after 33 years - Wisconsin State Farmer

Cold Plasma Market is projected to reach a market value of by US$ 51314.6 Mn by 2026 end – Jewish Life News

With the advancing electronics and semiconductors industry, the demand for cold plasma (CP) has been on the rise. While the demand for applications such as coating and finishing, surface treatment, adhesion, and etching, associated with printed circuit boards (PCBs) is soaring, the market for cold plasma is also expected to benefit from a slew of applications arising in other end use industries. Moreover, increasing applications in food safety will also push the market for cold plasma further, over the next few years. As depicted in a recent research report published by Persistence Market Research (PMR), the US$ 1.4 Bn global cold plasma market is presumed to observe stellar growth over an eight-year projection period. Between 2018 and 2026, the cold plasma market will possibly expand at a CAGR of 16.3%, as indicated by PMRs globalcold plasma marketreport.

The potential applications of cold plasma technology traverse a wide range, including the extension of product shelf-life and environmental sustainability. Such applications have been attracting the scientific community towards cold plasma research, over the years. The CP technique has already been proven to be an economic and environment-friendly technology in the textile industry. Textile companies are increasingly adopting cold plasma technique in an effort to deliver improved textile finishing.

Request For Report [emailprotected]https://www.persistencemarketresearch.com/samples/17053

Cold Plasma Technology Soon to Transform Wound Treatment Space

While cold plasma applications in sterilization and disinfection are currently accounting for maximum revenue in the cold plasma market, rapidly emerging applications in wound healing and adhesion will reportedly create lucrative opportunities for stakeholders.

Coldplasmatech GmbH, a German company, is looking forward to introduce a novel CP technology that could potentially revolutionize the wound care treatment platform, especially in emergency rooms in hospitals. The CP technology involves a patch of cold plasma made of silicone (as a part of the wound dressing), which can be used in treatment of chronic wound infections with the help of UV radiations and ions. This technology is presumed to provide a high-tech, efficient alternative to antibiotics, considering its ability to accelerate the wound healing process. If the trials based on the application of the cold plasma technology in faster wound healing deliver convincing and viable results, industry experts predict that the CP technology could become a widespread method for treatment of chronic wounds and infection, in near future.

Cold Plasma Technology to Win Preference over Conventional Processing Technologies

Among all end use industries generating demand for cold plasma, electronics and semiconductors are foreseen to reign supreme. Whereas, rising demand for cold plasma is expected to uplift the prospects for cold plasma in food processing and packaging, and plastics and polymers industries.

Advanced cold plasma technology is being widely used in the in-package decontamination of fresh foods. Shelf-life extension will also remain a key objective of fresh food industry participants, using cold plasma as a unit technology. With successful trials of the regulation of contaminants mediated by cold plasma, the applications of cold plasma in agriculture sector are expected to surge in near future. Additionally, research shows that it is possible to degrade the chemical residues of pesticides to relatively lesser toxic and safer structures, by using cold plasma. It also offers an excellent alternative to conventional fertilizers and pesticides.

As far as the processed and packaged food industry is concerned, cold plasma has been proven to hold immense potential as a safe and eco-friendly alternative to traditionally used chemical processes. Moreover, it is considered as a novel non-thermal technology for processing of foods, especially fruits and vegetables, and poultry and meat prominently attributed to the non-thermal nature, versatile design, and economic pricing of cold plasma. Research findings also confirm that cold plasma treatment poses no or minimal impact on a products chemical, physical, sensory, and nutritional attributes. However, it still remains to be seen whether cold plasma processing will completely replace the traditionally used processing technologies, as the research outcome is still in the pipeline and demands more extensive research in order to reach its potential.

Request Report [emailprotected]https://www.persistencemarketresearch.com/methodology/17053

Company Profiles

For in-depth competitive analysis, buy [emailprotected]https://www.persistencemarketresearch.com/checkout/17053

The rest is here:

Cold Plasma Market is projected to reach a market value of by US$ 51314.6 Mn by 2026 end - Jewish Life News

In Search of the Fountain of Youth Healthy Aging | Maximum Wellness – WWLTV.com

Aging, which is associated with a decline in an individuals physical and physiological capabilities, is part of life as in death and taxes.

NEW ORLEANS Based on research Calorie Restriction and Aging in Humans which appeared online in June of 2020 in the Annual Review of Nutrition over the past century, the average life span in higher- and lower-income countries has increased by 15 and 30 years, respectively.

Additionally, this (outcome) is the result of lessening mortality and morbidity from food shortage, malnutrition, and infectious diseases through improved food supply and quality, as well as, advances in health care.

Aging, which is associated with a decline in an individuals physical and physiological capabilities, is part of life as in death and taxes.

The speed and progression of age can be effected by such variables, as excess food consumption overweight and obesity, poor fitness less than 150 minutes of light to moderate weekly exercise, 75 minutes of moderate to vigorous weekly exercise, or a combination of both, or, the extent of an individuals exposure to disease all equaling secondary aging, added to or subtracted from (with prevention in place) the normal primary aging process.

According to the Annual Nutrition Reviews researchers from Pennington Biomedical Research Center, Louisiana State University, and Nutrition and Movement Sciences at Maastricht University in the Netherlands, advanced age is associated with increased mortality and susceptibility to disease. This increase is caused by a progressive decline in physiological function. The slope of this decline over time can be defined as aging, which, under an optimal scenario, may approach 120 years.

Primary aging, note the researchers, describes the inevitable age-associated decline in physiological and physical functions due to energy expenditure and oxidative stress. It appears that individuals with higher metabolic rates have shorter life spans - known as the rate-of-living theory - which the Pennington and Maastricht researchers say is, still a matter of discussion, and may only apply in species, and not between species.

It was also noted that average lifespan is reduced to 61 to 83 years an acceleration of this process reflects the interaction between innate aging and the extrinsic influences of the environment.

As aging applies to our functional capacity, Ive often commented to many of my athlete clients when my patience (with age) wears thin - discussing my strategic plan that age is mandatory, but maturity is optional.

Theyve also heard me explain from day one that my objective is to make them perform better than before with a higher quality of health in the years extending beyond their playing career.

I recognize three ages chronological age, what were given at birth, performance age, how successful we are at achieving our mental and physical objectives on and off the playing field, and health age, resistance to the effects of chronic fatigue and disease.

With the exception of our chronological age, being the constant, the goal from a health age perspective is to work toward a compressed morbidity, pushing illness to the shortest period of time late in life which is extended toward a higher quality.

The pillars of life extension slowing the aging process has to do with lengthening the telomeres - segments of DNA occurring at the ends of the chromosomes in eukaryotic cells (that containing a clearly defined nucleus), according to Britannica.com.

Notes the website, once telomeres have been reduced to a certain size, the cell reaches a crisis point and is prevented from dividing further. As a consequence, the cell dies. Thus, the processes of cell aging and cell death are regulated in part by telomeres.

Calorie restriction (CR) has been shown to increase life span from 1 to 5 years in animal studies - with some human support. However, for those over 60, the potential increase in life span may be offset by the potential for loss of lean muscle mass in light of sarcopenia the aging loss of muscle. Daily protein intake may need to increase from 0.8 grams per kilogram of body weight to 1.2 grams.

The nutrient resveratrol, found in red grape skins, peanuts, red wine, and in supplement form has been demonstrated to mimic CR, but the optimum dosage and administration is still being investigated.

The key to living a healthier, longer life is to practice healthy eating the Mediterranean eating style, exercise using the guidelines outlined earlier in this

column, stress control opting for meditation, controlled breathing, even prayer, laughing, associating with friends, giving and receiving love human or pet, and common sense during troubling times. Its not that hard.

Add, a dose of passion a life force that allows you to reinvent yourself on a daily basis, and you place yourself on the path toward the elisive fountain of youth.

Sign up for Mackie Mail, on mackieshilstone.com - my free, weekly wellness update with Fitness in Small Spaces 90-second videos Monday, my Maximum Wellness podcast and script on Wednesday, and, on Friday you receive my WWL/WUPL 3-minute Workout Wednesday segment. You can also contact spencer@mackienutrition.com should you desire nutrition product shipped or locally delivered to your door. My 4 locally operated GNC franchise stores are open, regularly sanitized with appropriate staff and customer safety in place. Check mackieshilstone.com for store locations and hours.

Get breaking news from your neighborhood delivered directly to you by downloading the new FREE WWL-TV News app now in theIOS App StoreorGoogle Play.

Stay up-to-date with the latest news and weather in the New Orleans area on the all-new free WWL TV app. Our app features the latest breaking news that impacts you and your family, interactive weather and radar, and live video from our newscasts and local events. LOCAL & BREAKING NEWS * Receive r...

More:

In Search of the Fountain of Youth Healthy Aging | Maximum Wellness - WWLTV.com

Alex Ovechkin on a possible contract extension with the Capitals: I’m ‘not even talking, not even thinking about it’ – Russian Machine Never Breaks

Alex Ovechkins historic 13-year, $124 million contract ends after the 2020-21 season. Monday, July 13, 2020, marked an important milestone for both Ovechkin and the Washington Capitals. Per the new NHL CBA, its the first official day Ovechkin could sign a new contract extension with the only team hes ever played for in the NHL.

After the first day of Phase 3 training camp, Ovechkin was asked if hes had any discussions with general manager Brian MacLellan about a new deal.

His answer was a hard no.

The Great 8 talks with media from Day One of Phase 3#ALLCAPS pic.twitter.com/nqy70fpNrD

Washington Capitals (@Capitals) July 13, 2020

No. Like not even talking, Ovechkin said. Not even thinking about it because right now we have lots of things to do.

For Ovechkin, that means preparing for an unprecedented postseason that will see the Capitals enter a bubble away from their families and play playoff games in an empty Scotiabank Arena. The Capitals captain could be away from his wife Nastya and two sons, Sergei and Ilya, for months as he tries to win his second Stanley Cup in three years.

Every player wants to play for a Cup, right? Ovechkin said. We have that opportunity right now to go back and hope we going to win. Obviously, if you look at our roster, we have very good group of guys, experienced guys, and talented guys. Im looking forward to it.

Its possible the coronavirus pandemic could cost Ovechkin millions of dollars in a new deal. Last week after the new CBA was signed, the NHL announced that next seasons salary cap will remain flat ($81.5 million) and the cap will not go up in future years until revenue reaches $4.8 billion. Before the pandemic suspended the season, NHL commissioner Gary Bettman said the cap could be as high as $88.2 million for the 2020-21 season.

The Capitals, who are airtight against the current salary cap of $81.5 million right now, have several players coming off the books this fall. Braden Holtby ($6.1 million cap hit) and Radko Gudas ($2.35M) are unrestricted free agents along with trade deadline acquisitions Brenden Dillon ($1.64M) and Ilya Kovalchuk ($350k). Ovechkin is currently the teams only UFA in 2021.

Nicklas Backstrom, who re-signed with Washington in January, called himself lucky that his new five-year, $46 million deal was inked before the season was suspended.

Asked about re-signing in January (prior to the Covid mess), Backstrom cracked, "I've heard it from many, many people that I got lucky. Sometimes you got to be lucky." #Caps

Tarik El-Bashir (@Tarik_ElBashir) July 13, 2020

Ovechkin has signaled in past interviews that hed like to end his career in Washington. Ive been playing only for two teams in my life: Dynamo Moscow and the Caps, Ovechkin said in March 2019. I dont like too much to change teams.

In a September podcast interview, he pestered Nicklas Backstrom to re-sign with Washington so they could end their careers together.

You gonna sign six more years and then Ill sign for five more years, Ovechkin said.

According to Backstrom, Ovechkin asked him every day at practice if he had re-signed with the Caps. They hugged when the deal was finally done.

Capitals owner Ted Leonsis communicated in December that he expected both players to end their careers in DC.

Well work it out, Leonsis said. And I hope to build the organization so that carries over. I would expect an Alex, a Nick, they play here forever, then they retire and then theyre associated with us very, very closely through alumni, through who knows whatever kinds of relationships.

Hopefully, the realities of the COVID-19 pandemic hasnt changed those plans.

Original post:

Alex Ovechkin on a possible contract extension with the Capitals: I'm 'not even talking, not even thinking about it' - Russian Machine Never Breaks

Other Viewpoints: Why is AG Barr going after Google? – The Columbus Dispatch

For months, President Donald Trumps Justice Department has hinted that it intends to crack down on Silicon Valley. It recently took a big step closer as senior antitrust officials met with their state counterparts to plot out a case against Alphabet Inc.s Google. Quite what they plan to argue isnt yet clear. But as the final months of Trumps first term wind down, and an election draws near, some exceptional skepticism is in order.

One reason for caution is that Attorney General William Barr has not exactly been a disinterested enforcer of competition law. Quite the opposite: In recent testimony, a senior Justice Department whistleblower described how Barr pressured antitrust prosecutors to harass automakers (and others) for transparently political reasons.

Now, according to news reports, Barr has taken an unusual interest in the Google case. Why? In a recent interview with Fox News, he intimated that he hopes to use antitrust law to punish tech companies for censoring conservative viewpoints, a frequent preoccupation of Trumps. Never mind that this accusation is false, and that tech companies would be entirely within their rights to so discriminate if they chose. The whole thing has nothing to do with antitrust.

Perhaps Barr was musing idly, and perhaps the department has more legitimate objections in mind. But even under more traditional theories of competition law, Google makes an odd target.

Feasibly, a case might be made against its dominance of the online advertising market, for instance. Combined with Facebook, Google took in about 60% of digital ad spending last year. Yet theres no law against building a good product. And with pressure rising from Amazon and other contenders, online ad rates have fallen by more than 40% in the past decade. That doesnt look like a market lacking in competition.

Nor could anyone credibly argue that Google has harmed consumers, the standard traditionally applied in antitrust analysis. To the contrary, it gives them (among other things) access to limitless email, a smartphone operating system, innovative mapping software and a search engine that ranks among the greatest inventions of the past century all for free. Its targeted advertising has been a boon to businesses big and small. Thats to say nothing of its work on driverless cars, quantum computing or esoteric life-extension technologies.

Even an otherwise blameless company shouldnt get a pass for anticompetitive behavior, of course. And some allege that Google has unfairly privileged its own products, pursued harmful mergers and engaged in other dubious conduct. If the Justice Department imposed targeted remedies for such violations after a transparent investigation, it would be entirely appropriate.

Yet the Trump administration has suggested nothing of the sort publicly. If its track record is any guide, this case is more likely to amount to a political attack with a belabored legal rationale attached. Even if its motives are pure, the administration should be wary: Government intervention in a market where no obvious harm has been caused to consumers and in pursuit of vague or unrelated objectives is a recipe for disaster.

The fact is, for all the criticism leveled at tech companies, they employ hundreds of thousands of people, create immensely useful products, propel what growth the American economy still enjoys and are among the most trusted brands going. They need to follow the rules like everyone else. But abusing antitrust law to clobber them for electoral gain wont end well for anyone.

Bloomberg News

Follow this link:

Other Viewpoints: Why is AG Barr going after Google? - The Columbus Dispatch

ABMS Announces Progressive Leave Policy for Residents and Fellows – PRNewswire

CHICAGO, July 13, 2020 /PRNewswire/ --The American Board of Medical Specialties (ABMS), the leading not-for-profit organization that oversees physician certification in the United States, announced the adoption of a progressive leave policy that will offer residents and fellows more flexibility, reduce stress, and increase autonomy in making life decisions, especially with regard to family and parental leave.

Starting in July 2021, all ABMS Member Boards with training programs of two or more years duration will allow for a minimum of six weeks away once during training for purposes of parental, caregiver, and medical leave, without exhausting time allowed for vacation or sick leave and without requiring an extension in training. Member Boards must communicate when a leave of absence will require an official extension to help mitigate the negative impact on a physician's career trajectory that a training extension may have, such as delaying a fellowship or moving into a full, salaried position.

"The growing shifts in viewpoints regarding work-life balance and parental roles had a great influence in the creation of this policy which fosters an environment that supports our trainees' ability to care not only for patients, but also for themselves and their families,"stated Richard E. Hawkins, MD, ABMS President and Chief Executive Officer."Several ABMS Member Boards have already adopted policies ensuring residents and fellows have the flexibility to manage their training commitments 'when life happens' and not unduly delay achievement of board certification. All of our Member Boards will extend these opportunities to residents as they implement the new policy during the next year."

The development of the new "ABMS Policy on Parental, Caregiver and Family Leave" was initiated following a report from the Accreditation Council on Graduate Medical Education's (ACGME) Council of Review Committee Residents in June 2019. An ABMS Task Force on Parental Leave was established and included Jo Buyske, MD, President and Chief Executive Officer, American Board of Surgery (ABS) and Carolyn Kinney, MD, Executive Director, American Board of Physical Medicine and Rehabilitation, both members of the ABMS Board of Directors Member; Nancy Rose, MD, representing the American Board of Medical Genetics and Genomics; and Julius Hamilton, MD, a cardiothoracic anesthesiologist and a member of the ABMS Stakeholder Council. ABMS and ACGME co-sponsored a workshop on resident and fellow parental and family leave in early February 2020 that brought together more than 80 multidisciplinary stakeholders to explore this issue and make recommendations for improvement.

"It is gratifying to see the high level of engagement and commitment from ABMS Member Boards to address an issue that is so important to physicians in training," said Dr. Kinney. "Through Member Boards' compassionate and creative efforts, we see that it is possible to maintain high standards for physician training while preserving trainees' physical and emotional well-being."

The newly approved policy offers ABMS Member Boards the flexibility to create a parental, family or medical leave protocol that best suits the training required for their specialty and/or subspecialty. Examples of this tailored approach include the American Board of Anesthesiology's (ABA) recent addition of 40 additional days (8 weeks) of absence from training over and above the existing 60 days absence permitted, subject to approval by the ABA, without extending training, and ABS' six-year residency option, under which a resident may take up to 12 months leave during the training period if needed. The American Board of Obstetrics and Gynecology allows a resident to take up to a total of 24 weeks (six months) of leave over the four years of residency, not to exceed 12 weeks in a single year.

Kristy Rialon, MD, one of the authors of the ACGME report, welcomes this change. "By virtue of their ages, residents and fellowsmale and femaleoften find themselves having and raising children, as well as serving as family members' caregivers," said Dr. Rialon, Assistant Professor of Surgery at Baylor College of Medicine and the Texas Children's Hospital. "By adopting more realistic and compassionate approaches, the ABMS Member Boards will significantly improve the quality of life for residents and fellows. This also will support our female physicians, helping to narrow the gender gap in their career advancement by allowing for greater leave flexibility."

About ABMSEstablished in 1933, the American Board of Medical Specialties (ABMS) is the leading not-for profit organization overseeing physician certification in the United States. ABMS supports 24 Member Boards that develop educational and professional standards and programs of assessment to certify physician specialists, all dedicated to improving the quality of care to the patients, families and communities they serve. More than 900,000 physicians are certified in one or more of 40 specialties and 87 subspecialties offered by the ABMS Member Boards. For more information about ABMS, visit abms.org or call (312) 436-2600.

SOURCE American Board of Medical Specialties

Home

Originally posted here:

ABMS Announces Progressive Leave Policy for Residents and Fellows - PRNewswire